Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 50 of 715 entries
View as:

Efficacy, Safety and Tolerability of Topical 10% Terbinafine Hydrogen Chloride Versus 5% Amorolfine Nail Lacquer in Patients With Mild to Moderate Toenail Onychomycosis

Phase: N/A Priority: Normal
NCT ID: NCT00459537 Org: User:
Start: 03/31/07 End: 01/31/09 Due: 01/31/10

Long Term Safety of Aliskiren Alone or With the Optional Addition of Hydrochlorothiazide in Patients With Essential Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00219037 Org: User:
Start: 06/30/04 End: 10/31/05 Due: 10/31/06

Valsartan/Hydrochlorothiazide Combination in Hypertensive Patients Not Controlled With Valsartan Alone

Phase: N/A Priority: Normal
NCT ID: NCT00170989 Org: User:
Start: 09/30/04 End: 07/31/05 Due: 07/31/06

VALIDATE Valsartan and Supportive Measures - Impact on Drug Adherence of Treated Hypertensive Patients

Phase: N/A Priority: Normal
NCT ID: NCT00394823 Org: User:
Start: 11/30/05 End: 06/30/07 Due: 06/30/08

A Study to Evaluate the Safety/Tolerability and Pharmacokinetics of Aliskiren in Hypertensive Pediatric and Adolescent Patients 6-17 Years of Age

Phase: N/A Priority: Normal
NCT ID: NCT00834041 Org: User:
Start: 04/30/09 End: 01/31/10 Due: 01/31/11

Safety and Tolerability of Vildagliptin Versus Sitagliptin in Patients With Type 2 Diabetes and Severe Renal Insufficiency (28-week Extension Study)

Phase: N/A Priority: Normal
NCT ID: NCT00770081 Org: User:
Start: 09/30/08 End: 04/30/11 Due: 04/30/12

Antibody Levels Associated With Reduced Risk of Invasive Group B Streptococcus Disease in Infants Aged Less Than 90 Days

Phase: N/A Priority: Normal
NCT ID: NCT02099149 Org: User:
Start: 05/31/14 End: 08/31/15 Due: 08/31/16

Zoledronic Acid in MS-patients With Osteoporosis

Phase: N/A Priority: Normal
NCT ID: NCT01166178 Org: User:
Start: 10/31/10 End: 06/30/12 Due: 06/30/13

Effects of Aliskiren and Amlodipine on the Renin-Angiotensin System (RAS) and Lipid/Carbohydrate Metabolism in Obese Patients With Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00498433 Org: User:
Start: 06/30/07 End: 03/31/12 Due: 03/31/13

Long Term Safety of Vildagliptin (100mg qd) In Patients With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00389415 Org: User:
Start: 10/31/06 End: - Due: -

A Study to Compare Treating Hypertension With Valsartan 160 MG to Valsartan 320 Mg

Phase: N/A Priority: Normal
NCT ID: NCT00241137 Org: User:
Start: 09/30/03 End: 01/31/05 Due: 01/31/06

Comparison of Two Treatment Strategies in Hypertensive Patients

Phase: N/A Priority: Normal
NCT ID: NCT00171444 Org: User:
Start: 06/30/04 End: 05/31/05 Due: 05/31/06

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics of AEB071

Phase: N/A Priority: Normal
NCT ID: NCT00409929 Org: User:
Start: 06/30/06 End: - Due: -

Efficacy and Safety of Tegaserod in Opioid-induced Constipation in Patients With Non-cancer Pain

Phase: N/A Priority: Normal
NCT ID: NCT00365820 Org: User:
Start: 07/31/06 End: 04/30/07 Due: 04/30/08

Efficacy and Safety of Acetaminophen, Aspirin and Caffeine With Sumatriptan in the Acute Treatment of Migraine

Phase: N/A Priority: Normal
NCT ID: NCT01248468 Org: User:
Start: 11/30/10 End: 03/31/11 Due: 03/31/12

Evaluation of Safety and Efficacy of Artemether-Lumefantrine Tablets in African Infants and Children With Uncomplicated P. Falciparum Malaria

Phase: N/A Priority: Normal
NCT ID: NCT00709969 Org: User:
Start: 07/31/02 End: 02/28/03 Due: 02/28/04

The VALIDATE Study of Valsartan for Patients With Early Stage Heart Failure

Phase: N/A Priority: Normal
NCT ID: NCT00241098 Org: User:
Start: 05/31/03 End: 06/30/05 Due: 06/30/06

Phase 4 Study in the Elderly Patients With T2DM

Phase: N/A Priority: Normal
NCT ID: NCT01238978 Org: User:
Start: 10/31/10 End: 12/31/11 Due: 12/31/12

Dose Finding, Safety and Efficacy of Monthly Subcutaneous Canakinumab Administration in Metformin Monotherapy Treated Type 2 Diabetic Patients

Phase: N/A Priority: Normal
NCT ID: NCT00900146 Org: User:
Start: 04/30/09 End: 11/30/10 Due: 11/30/11

A Study to Compare the Efficacy of QAV680 Against Placebo in Treating Seasonal Allergic Rhinitis in an Environmental Exposure Chamber

Phase: N/A Priority: Normal
NCT ID: NCT00784732 Org: User:
Start: 09/30/08 End: 12/31/08 Due: 12/31/09

The Efficacy and Safety of Oral Oxcarbazepine 300-1200 mg/Day as Adjuvant Therapy in the Treatment of Adolescents With Impulsivity and Aggressive Behavior in Conduct Disorder This Study is Not Being Conducted in the United States.

Phase: N/A Priority: Normal
NCT ID: NCT00154362 Org: User:
Start: 04/30/03 End: 10/31/04 Due: 10/31/05

Efficacy and Safety of ACZ885 in Patients With the Following Cryopyrin-associated Periodic Syndromes: Familial Cold Autoinflammatory Syndrome, Muckle-Wells Syndrome, or Neonatal Onset Multisystem Inflammatory Disease

Phase: N/A Priority: Normal
NCT ID: NCT00685373 Org: User:
Start: 05/31/08 End: 04/30/10 Due: 04/30/11

Efficacy of the New Closure Device in Improving Patient Compliance in Treatment of Hypertension With Valsartan+/-Hydrochlorothiazide (HCTZ) at 6 Months

Phase: N/A Priority: Normal
NCT ID: NCT00487123 Org: User:
Start: - End: 09/30/07 Due: 09/30/08

Study to Evaluate the Safety of Novartis MenACWY Conjugate Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants

Phase: N/A Priority: Normal
NCT ID: NCT00806195 Org: User:
Start: 12/31/08 End: 11/30/11 Due: 11/30/12

Pharmacokinetic Evaluation of an 8 -Week Treatment With Inhaled Tobramycin

Phase: N/A Priority: Normal
NCT ID: NCT00634192 Org: User:
Start: 02/29/08 End: 08/31/09 Due: 08/31/10